SCHEMBL8562833

SCHEMBL8562833

CC(C)(C)[Si](OCCc1ccc(Cl)c(C(=O)O)c1Cl)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMYD2 Q9NRG4 2/20 0.33
CYP3A4 P08684 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 1/20 0.32
CLCN2 P51788 1/20 0.32
DPP4 P27487 1/20 0.32
BCL2 P10415 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21684541 0.72 ALDH1A1 (0.41) ALDH1A1SMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL3537609 0.71 PTGER4 (0.56) KDM4EHSD17B10
SCHEMBL2927140 0.71 PPARG (0.34) KDM4ESMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL25328099 0.71 ALDH1A1 (0.42) KDM4EALDH1A1SMYD2CYP3A4HTT
SCHEMBL29102862 0.71 SMYD2 (0.38) ALDH1A1SMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL1291772 0.70 LMNA (0.42) ALDH1A1SMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL23528479 0.70 SMYD2 (0.36) KDM4EALDH1A1HSD17B10SMYD2CYP3A4
SCHEMBL29051719 0.70 LMNA (0.47) KDM4ESMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL4479571 0.70 SMYD2 (0.35) SMYD2CYP3A4HTTSMN1; SMN2
SCHEMBL29967957 0.70 SMYD2 (0.36) SMYD2CYP3A4HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863881-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-09-16 EP disclosed
WO-1997010219-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-20 WO disclosed